Long-form research.
Mechanism · administration · safety.

Semax and Selank are Soviet-era synthetic peptides developed in Russia during the 1970s–80s and still prescribed there today for stroke recovery, anxiety disorders, and cognitive decline. Unlike stimulants (which flood the brain with dopamine) or sedatives (which suppress neuronal activity), these peptides work by upregulating the brain's own growth and repair factors. Semax stimulates the production of BDNF — brain-derived neurotrophic factor — a protein critical for learning, memory, and neuronal survival. Selank modulates the GABA system, the brain's primary calming pathway, producing anxiolytic effects without the sedation or dependence risk of benzodiazepines. A key practical advantage: both are administered as nasal sprays, bypassing the need for injections.

Thymosin Alpha-1 stands apart from most research peptides by having the most robust clinical validation: it is an approved pharmaceutical (Zadaxin®) in over 35 countries including Italy, China, and various Asian and Eastern European nations. The thymus gland produces Thymosin Alpha-1 naturally to "educate" T-cells — white blood cells that coordinate the immune response. As we age, thymic output declines, and with it the efficiency of our immune surveillance. Thymosin Alpha-1 is studied to restore this immune competence: activating natural killer cells, boosting T-cell populations, and enhancing the body's response to vaccines and infections. It is of particular interest to self-researchers focused on immune optimisation, post-illness recovery, and age-related immune decline.

Sleep quality is increasingly recognised as one of the most powerful levers for health, cognitive performance, and longevity. DSIP (Delta Sleep-Inducing Peptide) was discovered in 1977 when researchers isolated it from rabbit blood during natural sleep and found that injecting it into alert rabbits induced slow-wave (deep) sleep within 30 minutes. Unlike sleeping pills, which work by broadly suppressing brain activity, DSIP specifically promotes delta-wave (slow-wave) sleep — the deepest and most restorative stage — without sedation, respiratory depression, or dependence. Selank contributes to this category through its anxiolytic mechanism: by reducing the hyperarousal (racing thoughts, elevated cortisol, difficulty switching off) that underlies stress-induced insomnia, without the muscle-relaxing or respiratory effects of benzodiazepines.

PT-141, known clinically as Bremelanotide and sold as Vyleesi®, is the only FDA-approved peptide specifically for sexual dysfunction — approved in 2019 for hypoactive sexual desire disorder in premenopausal women. What makes PT-141 unique is where it acts: not in the blood vessels, like Viagra or Cialis, but in the brain. It activates melanocortin receptors in the hypothalamus — a region involved in desire, arousal, and motivation — producing an increase in sexual interest that is centrally driven rather than mechanically facilitated. This makes it relevant for addressing the desire and psychological components of sexual dysfunction, which PDE5 inhibitors cannot reach. It has been studied in both men and women, giving it one of the broadest clinical research bases of any peptide on this site.

CJC-1295, Ipamorelin, GHK-Cu, IGF-1 LR3 son los péptidos más investigados para crecimiento muscular. Todos prohibidos por WADA. Atletas probados en LATAM deben evitar todos. Investigación no institucional sujeta a marcos regulatorios nacionales (Cofepris, ANMAT, etc.).

Tirzepatide y Semaglutide aprobados como medicamentos en LATAM han transformado el espacio de péptidos para pérdida de peso. AOD-9604 y otros siguen siendo research-use-only. Acceso farmacéutico regular es generalmente preferible a importación transfronteriza cuando es posible.

BPC-157 y TB-500 son los péptidos más investigados en curación y regeneración. Mecanismos complementarios — vía NO/VEGF (BPC-157) y polimerización de actina (TB-500). Prohibidos por WADA. Investigadores LATAM acceden vía importación transfronteriza con riesgo aduanero variable.

Epithalon (telomerasa, investigación rusa Khavinson), GHK-Cu (modulación génica), y FOXO4-DRI (senolítico) son los principales compuestos de longevidad research-use-only. Todos bajo S0 en WADA. Investigadores LATAM acceden vía importación transfronteriza; la cadena de frío es crítica.

México tiene uno de los marcos regulatorios LATAM más manejables para péptidos research-use-only. Cofepris regula formalmente pero no enforces contra compradores individuales. Importación transfronteriza con declaración research-use-only es la realidad operativa. Universidades mantienen vías institucionales limpias.

Argentina tiene un marco regulatorio más estricto que México pero menos que Brasil. ANMAT enfoca cumplimiento contra vendedores con afirmaciones terapéuticas, no contra compradores individuales. Cryptocurrency es esencial dada la situación cambiaria argentina.

LATAM hispanohablante presenta un mosaico de marcos regulatorios. México es más manejable; Argentina más controlada cambiariamente; Chile / Colombia / Perú intermedios. Investigación institucional vía consejos nacionales y universidades es siempre más limpia que importación individual.

Particle Peptides retiene 2026 LATAM Editor's Choice por rigor de pruebas (7 parámetros) y soporte parcial en español. SwissChems es la opción para mayor comisión de afiliados y catálogo amplio. Ningún vendedor LATAM-doméstico — todas las compras transfronterizas. Cryptocurrency esencial para compradores argentinos.

Particle Peptides gana en rigor de pruebas (7 parámetros) y base de reseñas (308 verificadas). SwissChems gana en comisión de afiliados (20%) y catálogo amplio. Investigadores institucionales y calidad-conscientes deben elegir Particle Peptides. Creadores de contenido pueden preferir SwissChems por la comisión.